Nitric Oxide During CPB to Reduce AKI in Neonates

Summary

This is a prospective, randomized, double-blind, placebo-controlled pilot study to investigate whether supplemental Nitric Oxide (NO) gas delivered during cardiac surgery with cardiopulmonary bypass (CPB) reduces the incidence and impact of acute kidney injury (AKI) in neonates undergoing surgery for congenital heart disease (CHD), when compared to placebo gas

Timeline

Start

2021-10

Primary completion

2022-10

Completion

2023-03

Outcome

Outcome not reported

Stopped: “This study could not be started because of some technical issues.”

Drugs

Indications